Clinical trials: Azithromycin, completed
COVID-19, Mild to Moderate
COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU
This is a retrospective observational cohort study. About 1000 hospital charts of adult patients admitted to the hospital with mild-to-moderate COVID-19 from February to August 2020 were analyzed to evaluate the inflammatory…
- Trial name
- NCT05302947
- Testing
- Baricitinib Oral Tablet, Tocilizumab Injection, Netakimab
- Where
- 2 sites in Russia
- Volunteers
- 154 people
- Sponsor
- Pirogov Russian National Research Medical University
COPD, Inhaled Corticosteroid
Eosinophil-guided Reduction of Inhaled Corticosteroids
Clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid (ICS) therapy and prophylactic azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease…
- Conditions
- COPD, Inhaled Corticosteroid, Azithromycin, COPD Exacerbation
- Trial name
- COPERNICOS (NCT04481555)
- Testing
- Azithromycin, ICS
- Where
- 9 sites in Denmark
- Volunteers
- 444 people
- Sponsor
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Coronavirus, Iatrogenic Disease
Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
The outbreak of Covid-19 started several clinical trials and treatment experiments all over the world in the first months of 2020.
- Conditions
- Coronavirus, Iatrogenic Disease, Acute Kidney Injury, ARDS, Human
- Trial name
- CovidTox (NCT04314817)
- Testing
- Any drug used to treat Covid-19
- Where
- France
- Volunteers
- 1,000 people
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere
Childhood Mortality
Mortality Reduction After Oral Azithromycin: Morbidity Study
The long-term goal of this study is to more precisely define the role of mass azithromycin treatments as an intervention for reducing childhood morbidity and increasing growth, and for the potential selection of antibiotic…
- Trial name
- MORDORMorb (NCT02048007)
- Testing
- Azithromycin
- Where
- 6 sites in United States, Malawi and 3 more
- Volunteers
- 72,000 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Eye Infections, Bacterial
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
To compare the ocular tolerance, the safety and the ocular pharmacokinetics of 3 concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225 after one drop instillation
- Trial name
- NCT00357292
- Testing
- Azithromycin (T1225)
- Volunteers
- healthy volunteers welcome
- Sponsor
- Laboratoires Thea
Malaria in Pregnancy, Sexually Transmitted Infections
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
The purpose of this study is to determine whether repeated courses of sulphadoxine-pyrimethamine (SP) in combination with azithromycin given at Antenatal Clinic, leads to lower rates of low birth weight deliveries (<2.5 kg) among…
- Conditions
- Malaria in Pregnancy, Sexually Transmitted Infections, Anaemia
- Trial name
- IPTp in PNG (NCT01136850)
- Testing
- chloroquine, sulphadoxine pyrimethamine, LLIN, azithromycin, sulphadoxine pyrimethamine, LLIN
- Where
- Papua New Guinea
- Volunteers
- 2,793 people, healthy volunteers welcome
- Sponsor
- University of Melbourne
IMMUNOTHERAPY
Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients
Out of 49 early-stage critically-ill COVID-19 patients, 21 patients are the experimental group who take convalescent plasma compared to 28 patients receive only conventional therapy without taking Convalescent plasma.
- Trial name
- NCT04441424
- Testing
- Convalescent plasma, Hydroxychloroquin with Azithromycin
- Where
- Iraq
- Volunteers
- 49 people
- Sponsor
- Alkarkh Health Directorate-Baghdad
Coronary Disease, Heart Diseases
Azithromycin and Coronary Events Study (ACES)
To determine whether treatment with azithromycin decreases the rate of coronary heart disease events among patients with stable documented coronary artery disease.
- Conditions
- Coronary Disease, Heart Diseases, Myocardial Infarction, Cardiovascular Diseases
- Trial name
- NCT00000617
- Testing
- azithromycin
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Malaria
Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.
This trial sets out to determine whether the combination of azithromycin and artesunate (AZ+AS) is as good as the current standard treatment for uncomplicated malaria in Tanzania, artemether-lumefantrine (AL).
- Trial name
- CAZAMS (NCT00694694)
- Testing
- azithromycin + artesunate, artemether-lumefantrine
- Where
- Tanzania
- Volunteers
- 261 people
- Sponsor
- London School of Hygiene and Tropical Medicine
Normal Physiology, Healthy
Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)
More than 250 million courses of antibiotics are prescribed annually in the ambulatory care setting in the United States alone, including more than 40 million in children under 18 years of age.
- Trial name
- NCT02707042
- Testing
- Amoxicillin, Azithromycin, Control
- Where
- United States
- Volunteers
- 108 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Cystic Fibrosis
Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
The purpose of this study is to determine antimycobacterial drug pharmacokinetics (PK) and pharmacodynamics (PD) in patients with cystic fibrosis (CF) to improve treatment of nontuberculous mycobacterial (NTM) lung disease.
- Trial name
- NCT02372383
- Testing
- Ethambutol, Rifampin, Azithromycin
- Where
- United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Blepharitis
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).
- Trial name
- NCT01089608
- Testing
- Azithromycin, Povidone
- Where
- France
- Volunteers
- 93 people
- Sponsor
- Laboratoires Thea